Parion Sciences Announces $15.6 Million in Grant Support for Pulmonary Research Program October 15, 2014News & EventPSPaul Boucher Continue reading Parion Sciences Announces $15.6 Million in Grant Support for Pulmonary Research Program →
Parion Sciences Dry Eye Program Recognized by National Eye Institute (NEI) October 2, 2014News & EventPaul Boucher View Entire Article
Parion Sciences Announces $3 Million Award from Cystic Fibrosis Foundation Therapeutics to Accelerate the Development of Novel CF Treatment September 16, 2014News & EventPSPaul Boucher Continue reading Parion Sciences Announces $3 Million Award from Cystic Fibrosis Foundation Therapeutics to Accelerate the Development of Novel CF Treatment →
Parion Sciences Selected for Platform Presentation at the NHLBI Regional Innovation Conference to be Held on September 22nd at the NC Biotech Center September 11, 2014News & EventPaul Boucher Continue reading Parion Sciences Selected for Platform Presentation at the NHLBI Regional Innovation Conference to be Held on September 22nd at the NC Biotech Center →
Parion Sciences Selected as 2014 Tibbetts Award Recipient by the Small Business Administration (SBA) June 19, 2014News & EventPaul Boucher Continue reading Parion Sciences Selected as 2014 Tibbetts Award Recipient by the Small Business Administration (SBA) →
Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in Certain Asian Territories June 12, 2014News & EventPaul Boucher Continue reading Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in Certain Asian Territories →
Parion Sciences Announces Senior Leadership and Organizational Changes June 2, 2014News & EventPaul Boucher Continue reading Parion Sciences Announces Senior Leadership and Organizational Changes →
Parion Sciences Receives FDA Acceptance of the Investigational New Drug Application for Clinical Testing of P-321 Ophthalmic Solution for the Treatment of Dry Eye Disease May 1, 2014News & EventPaul Boucher Continue reading Parion Sciences Receives FDA Acceptance of the Investigational New Drug Application for Clinical Testing of P-321 Ophthalmic Solution for the Treatment of Dry Eye Disease →
Parion Sciences Reacquires Rights to Epithelial Sodium Channel Inhibitors April 30, 2014News & EventPaul Boucher Continue reading Parion Sciences Reacquires Rights to Epithelial Sodium Channel Inhibitors →
2013, May 22: tPAD Parion Cambridge Press Release November 22, 2013News & EventPaul Boucher Continue reading 2013, May 22: tPAD Parion Cambridge Press Release →
